Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Medicinova Inc (NQ: MNOV )

4.160 USD +0.110 (+2.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,618
Open 4.040
Bid (Size) 4.070 (1)
Ask (Size) 4.210 (3)
Prev. Close 4.050
Today's Range 4.040 - 4.210
52wk Range 3.870 - 13.25
Shares Outstanding 48,768,541
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MediciNova Reports First Quarter 2021 Financial Results and Business Update
From GlobeNewswire News Releases
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe
From GlobeNewswire News Releases

Performance

YTD
-21.06%
-21.06%
1 Month
-10.54%
-10.54%
3 Month
-31.47%
-31.47%
6 Month
-32.36%
-32.36%
1 Year
-24.91%
-24.91%

More News

Read More
MediciNova Receives Gene Therapy Milestone Payments
From GlobeNewswire News Releases
MediciNova to Participate in the B. Riley Neuroscience Conference
From GlobeNewswire News Releases
MediciNova to Participate in the UBS Global Healthcare Virtual Conference
From GlobeNewswire News Releases
Analysts Anticipate IBB Will Reach $195
Tags ETFs
From ETF Channel
IBB's Underlying Holdings Could Mean 31% Gain Potential
Tags ETFs
From ETF Channel
12 Health Care Stocks Moving In Friday's Intraday Session
Tags MRNS EVOK Markets
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags CCM CEMI Benzinga
From Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Tags SONN URGN GRAY
From Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Tags IPOs KALA EPZM
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]